Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer
10.1038/ng2064
Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., Aben, K. K., Strobbe, L. J., Albers-Akkers, M. T., Swinkels, D. W., Henderson, B. E., Kolonel, L. N., Le Marchand, L., Millastre, E., Andres, R., … Stefansson, K. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer. Nature Genetics, 39(7), 865–869.

Authors 53
  1. Simon N Stacey (first)
  2. Andrei Manolescu (additional)
  3. Patrick Sulem (additional)
  4. Thorunn Rafnar (additional)
  5. Julius Gudmundsson (additional)
  6. Sigurjon A Gudjonsson (additional)
  7. Gisli Masson (additional)
  8. Margret Jakobsdottir (additional)
  9. Steinunn Thorlacius (additional)
  10. Agnar Helgason (additional)
  11. Katja K Aben (additional)
  12. Luc J Strobbe (additional)
  13. Marjo T Albers-Akkers (additional)
  14. Dorine W Swinkels (additional)
  15. Brian E Henderson (additional)
  16. Laurence N Kolonel (additional)
  17. Loic Le Marchand (additional)
  18. Esther Millastre (additional)
  19. Raquel Andres (additional)
  20. Javier Godino (additional)
  21. Maria Dolores Garcia-Prats (additional)
  22. Eduardo Polo (additional)
  23. Alejandro Tres (additional)
  24. Magali Mouy (additional)
  25. Jona Saemundsdottir (additional)
  26. Valgerdur M Backman (additional)
  27. Larus Gudmundsson (additional)
  28. Kristleifur Kristjansson (additional)
  29. Jon T Bergthorsson (additional)
  30. Jelena Kostic (additional)
  31. Michael L Frigge (additional)
  32. Frank Geller (additional)
  33. Daniel Gudbjartsson (additional)
  34. Helgi Sigurdsson (additional)
  35. Thora Jonsdottir (additional)
  36. Jon Hrafnkelsson (additional)
  37. Jakob Johannsson (additional)
  38. Thorarinn Sveinsson (additional)
  39. Gardar Myrdal (additional)
  40. Hlynur Niels Grimsson (additional)
  41. Thorvaldur Jonsson (additional)
  42. Susanna von Holst (additional)
  43. Barbro Werelius (additional)
  44. Sara Margolin (additional)
  45. Annika Lindblom (additional)
  46. Jose I Mayordomo (additional)
  47. Christopher A Haiman (additional)
  48. Lambertus A Kiemeney (additional)
  49. Oskar Th Johannsson (additional)
  50. Jeffrey R Gulcher (additional)
  51. Unnur Thorsteinsdottir (additional)
  52. Augustine Kong (additional)
  53. Kari Stefansson (additional)
References 24 Referenced 588
  1. Amundadottir, L.T. et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med. 1, e65 (2004). (10.1371/journal.pmed.0010065) / PLoS Med. by LT Amundadottir (2004)
  2. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85 (2000). (10.1056/NEJM200007133430201) / N. Engl. J. Med. by P Lichtenstein (2000)
  3. Cannon-Albright, L.A. et al. Familiality of cancer in Utah. Cancer Res. 54, 2378–2385 (1994). / Cancer Res. by LA Cannon-Albright (1994)
  4. Smid, M. et al. Genes associated with breast cancer metastatic to bone. J. Clin. Oncol. 24, 2261–2267 (2006). (10.1200/JCO.2005.03.8802) / J. Clin. Oncol. by M Smid (2006)
  5. Easton, D.F. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1, 14–17 (1999). (10.1186/bcr6) / Breast Cancer Res. by DF Easton (1999)
  6. Balmain, A., Gray, J. & Ponder, B. The genetics and genomics of cancer. Nat. Genet. 33 Suppl., 238–244 (2003). (10.1038/ng1107) / Nat. Genet. by A Balmain (2003)
  7. Pharoah, P.D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33–36 (2002). (10.1038/ng853) / Nat. Genet. by PD Pharoah (2002)
  8. Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J. Natl. Cancer Inst. 98, 1382–1396 (2006). (10.1093/jnci/djj374)
  9. Cox, A. et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39, 352–358 (2007). (10.1038/ng1981) / Nat. Genet. by A Cox (2007)
  10. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999). (10.1111/j.0006-341X.1999.00997.x) / Biometrics by B Devlin (1999)
  11. Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S. & Hirschhorn, J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33, 177–182 (2003). (10.1038/ng1071) / Nat. Genet. by KE Lohmueller (2003)
  12. Trikalinos, T.A., Ntzani, E.E., Contopoulos-Ioannidis, D.G. & Ioannidis, J.P. Establishment of genetic associations for complex diseases is independent of early study findings. Eur. J. Hum. Genet. 12, 762–769 (2004). (10.1038/sj.ejhg.5201227) / Eur. J. Hum. Genet. by TA Trikalinos (2004)
  13. Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209–213 (2006). (10.1038/ng1706) / Nat. Genet. by AD Skol (2006)
  14. Johannsson, O.T. et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer 33, 362–371 (1997). (10.1016/S0959-8049(97)89007-7) / Eur. J. Cancer by OT Johannsson (1997)
  15. Honrado, E., Benitez, J. & Palacios, J. Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit. Rev. Oncol. Hematol. 59, 27–39 (2006). (10.1016/j.critrevonc.2006.01.006) / Crit. Rev. Oncol. Hematol. by E Honrado (2006)
  16. McVean, G.A. et al. The fine-scale structure of recombination rate variation in the human genome. Science 304, 581–584 (2004). (10.1126/science.1092500) / Science by GA McVean (2004)
  17. Winckler, W. et al. Comparison of fine-scale recombination rates in humans and chimpanzees. Science 308, 107–111 (2005). (10.1126/science.1105322) / Science by W Winckler (2005)
  18. Rakha, E.A., Green, A.R., Powe, D.G., Roylance, R. & Ellis, I.O. Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosom. Cancer 45, 527–535 (2006). (10.1002/gcc.20318) / Genes Chromosom. Cancer by EA Rakha (2006)
  19. James, J.J. et al. Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features. Br. J. Cancer 89, 660–665 (2003). (10.1038/sj.bjc.6601198) / Br. J. Cancer by JJ James (2003)
  20. Koenders, P.G. et al. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res. Treat. 18, 27–32 (1991). (10.1007/BF01975440) / Breast Cancer Res. Treat. by PG Koenders (1991)
  21. Barrett, J.C. & Cardon, L.R. Evaluating coverage of genome-wide association studies. Nat. Genet. 38, 659–662 (2006). (10.1038/ng1801) / Nat. Genet. by JC Barrett (2006)
  22. Kutyavin, I.V. et al. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 34, e128 (2006). (10.1093/nar/gkl679) / Nucleic Acids Res. by IV Kutyavin (2006)
  23. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131–138 (2003). (10.1038/ng1245) / Nat. Genet. by S Gretarsdottir (2003)
  24. Grant, S.F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320–323 (2006). (10.1038/ng1732) / Nat. Genet. by SF Grant (2006)
Dates
Type When
Created 18 years, 3 months ago (May 27, 2007, 1:22 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:14 p.m.)
Indexed 4 months, 2 weeks ago (April 11, 2025, 4:29 a.m.)
Issued 18 years, 3 months ago (May 27, 2007)
Published 18 years, 3 months ago (May 27, 2007)
Published Online 18 years, 3 months ago (May 27, 2007)
Published Print 18 years, 1 month ago (July 1, 2007)
Funders 0

None

@article{Stacey_2007, title={Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer}, volume={39}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/ng2064}, DOI={10.1038/ng2064}, number={7}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Stacey, Simon N and Manolescu, Andrei and Sulem, Patrick and Rafnar, Thorunn and Gudmundsson, Julius and Gudjonsson, Sigurjon A and Masson, Gisli and Jakobsdottir, Margret and Thorlacius, Steinunn and Helgason, Agnar and Aben, Katja K and Strobbe, Luc J and Albers-Akkers, Marjo T and Swinkels, Dorine W and Henderson, Brian E and Kolonel, Laurence N and Le Marchand, Loic and Millastre, Esther and Andres, Raquel and Godino, Javier and Garcia-Prats, Maria Dolores and Polo, Eduardo and Tres, Alejandro and Mouy, Magali and Saemundsdottir, Jona and Backman, Valgerdur M and Gudmundsson, Larus and Kristjansson, Kristleifur and Bergthorsson, Jon T and Kostic, Jelena and Frigge, Michael L and Geller, Frank and Gudbjartsson, Daniel and Sigurdsson, Helgi and Jonsdottir, Thora and Hrafnkelsson, Jon and Johannsson, Jakob and Sveinsson, Thorarinn and Myrdal, Gardar and Grimsson, Hlynur Niels and Jonsson, Thorvaldur and von Holst, Susanna and Werelius, Barbro and Margolin, Sara and Lindblom, Annika and Mayordomo, Jose I and Haiman, Christopher A and Kiemeney, Lambertus A and Johannsson, Oskar Th and Gulcher, Jeffrey R and Thorsteinsdottir, Unnur and Kong, Augustine and Stefansson, Kari}, year={2007}, month=may, pages={865–869} }